Fibromyalgia
Conditions
Interventions
The first intervention performed was the creation of two groups from the Study Patients with fibromyalgia were evaluated for 5 (five) weeks, considering the first (Ti) where the initial interview with
Sponsors
Universidade Federal de Sergipe
Eligibility
Sex/Gender
Female
Age
35 Years to 65 Years
Inclusion criteria
Inclusion criteria: Female; between 35 and 65 years old, previously diagnosed with fibromyalgia by an experienced anesthesiologist according to the criteria of the American College of Rheumatology, in the chronic pain outpatient clinic of the University Hospital of the Federal University of Sergipe.
Exclusion criteria
Exclusion criteria: Hypersensitivity to the tested drugs; Recent injury or trauma; diagnosis of epilepsy, psychiatric disorders,rheumatic disorders, moderate or severe neuromuscular disorders, hypothyroidism or hyperthyroidism, arthropathy, infectious disease, another chronic pain syndrome, neoplasms.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| It is expected pain ireduction, assessed using the visual analog scales (VAS) and Neuropathic Pain in 4 questions (DN4);;It is sought the reduction of oxidative stress levels assessed through the values of superoxide dismutase, catalase, malondealdehyde and Iron reduction power (FRAP) | — |
Secondary
| Measure | Time frame |
|---|---|
| It is expected a gradual reduction in pain intensity with maintenance of the effect even after two weeks fromlast intervention. This variable was assessed using the visual pain scale (VAS) and Neuropathic Pain in 4 questions (DN4) | — |
Countries
Brazil
Contacts
Public ContactJosé Nogueira
Universidade Federal de Sergipe
Outcome results
None listed